Email
Password
Remember meForgot password?
    Log in with Twitter

Pharmaceuticals News

Rebuilding the pharmacy from shop to digital: Interview Special

Washington - CaryRx is a pharmacy startup that has set out to rebuild the pharmacy concept from the ground up, through the use of a mobile app. To hear more about this next generation approach to pharmacies we spoke with company co-founder Areo Nazari.

Why data integrity is essential for the pharmaceutical sector Special

Otocec - Data integrity is necessary for ensuring the safety of medicine, helping to assure that release tests are correct and have not been corrupted. This was a key message at a recent Pharmig conference held in Slovenia.

Digital healthcare requires new workforce skills and strategy

Digital healthcare represents a fast-moving field. However, as a new survey indicates, job skills are creating unevenness within the field — and problems for the industry overall.

Digital health technology needs to be patient-centric

The next wave of digital health technology needs to focus on the patient experience, either in the way patients interact with technology or the way the use it. This is a key finding from a new report into the state of pharmaceuticals and healthcare.

Benchmarking the adoption of digital health technology

The tenth PwC report into the ‘digital health IQ’ of looks at the state of companies operating in the pharmaceutical and life sciences sector and it shows a faster, although sometimes uneven, rate of adoption of healthcare technology.

Screening for novel drugs using powerful computers

London - Searching for new types of drugs is a medical imperative. This is a complex task involving many types of diseases and chemical interactions. To assist with this process, Francis Crick Institute researchers have developed a new model.

Blockchain-powered supply chain tracker

When it comes to supply chain practices, pharmaceuticals must address the normal concerns of customer satisfaction and the control goods as well as strict regulatory requirements. To better produce medicines, a new high-tech sensor has been developed.

Pharmaceutical sector is waking up to big data

Pharmaceutical companies are showing an increased interest in big data, focused on areas like drug discovery and with a realization this can give them a competitive advantage. This might not come so easily, however, without a joined-up strategy.

Pharmaceuticals facing up to data integrity concerns

Pharmaceutical organizations are increasingly reliant upon automated systems and computers, from manufacturing to laboratory release testing. This has brought a renewed regulatory focus on the subject of data integrity.

Pharmaceutical cleaning validation simplified with new software

Washington - The company Quascenta has simplified cleaning validation for active pharmaceutical ingredient manufacturers through a new software package called eResidue. Cleaning validation is a key process, and it avoids cross-contamination.

Old drug sheds a new light on autism

University of California San Diego School of Medicine have completed an early phase clinical trial to evaluate the effectiveness of an established drug for the treatment of autism.

Herbal coffee recalled due to erectile dysfunction additive

Bethesda - A brand of herbal coffee has been recalled from the market after it was discovered that the product contained an unintended active pharmaceutical ingredient, designed to control erectile dysfunction.

Microbiologists assess ways to lower medicine contamination risks Special

Dublin - Microbiologists from a range of pharmaceutical and healthcare companies convened in Dublin to attend a conference discussing how to effectively monitor the built environment for risks in relation to drug product manufacturing.

Microbiologists review best practices for making medicines Special

Birmingham - The manufacture of medicines is at risk from cross-contamination from people, a result of the shedding of microorganisms. In February a special two-day conference considered how best to manage this risk.

Synthetic chemicals — An ignored risk to ecological change

Concerns over the proliferation of synthetic chemicals and pesticides, in particular, gave rise to the environmental movement in the 1960s. But scientific analysis of synthetic chemical pollution and their ecological impacts is disproportionately low.

Most drugs in sewage are not from dumped narcotics

Vermont - The belief that most drugs in sewage are stashes of illegal narcotics flushed down toilets by criminals appears to be a myth. Most drugs in sewage systems are excreted by people who have been prescribed them.

Pharma News: New products and new health initiatives announced

In the latest pharmaceutical news round-up there is a new push to eliminate polio, a new treatment for COPD, and unfortunate news that a patient has died after taking an anti-psychotic medication.

India wants to get in on the oil-for-loans deal with Venezuela

India wants to get in on the oil-for-loans deal that Venezuela has with China, in the hopes of recouping some of the millions of dollars in payments owed to India's largest pharmaceutical companies.

Big AZ takeover and other pharmaceutical news

As we do on a regular basis, Digital Journal has reviewed the latest developments within the pharmaceutical sector. Here AstraZeneca completes takeover of Takeda's respiratory business and Ferring Pharmaceuticals have a new nocturia treatment.

U.S. science center withdraws from sterile products manufacturing

Washington - The U.S. public-sector science base, the National Institutes of Health (NIH), has announced it will suspend all research related to sterile medicinal products after the test areas were found to be out of compliance with good practices.

Mixed news for Novartis

Pharmaceutical company Novartis experienced mixed results during the first quarter of 2016. Sales showed a decline, however the company is preparing to launch a significant new anti-seizure medication.

New leukemia and Zika drugs in the pipeline

Two very different drugs are making progress in news announced this week. The FDA has approved a new leukemia medication, and work is progressing on a Zika virus treatment.

Weekly pharmaceutical news roundup

This week has seen progress updates issued for new drug products for rheumatoid arthritis, skin dermatitis, and for hepatitis. Each of the products is at the clinical trial stage, and three of the drugs on offer are the result of partnerships.

Head of GSK to retire, and other pharma news

The head of GlaxoSmithKline is to retire, amid some concerns about the company’s performance. Digital Journal presents this and other news from the pharmaceutical sector, including mergers and FDA warnings.

List of largest medical fines revealed

The last couple of years have seen a slight lowering in the number of cases brought against medical companies; however, at the same time, there was an increase in the level of fines paid out.

Pharmaceutical sector round-up: Legal action dominates

As we do at regular intervals, Digital Journal dips into the latest news stories relating to the colorful world of pharmaceuticals. This week there are new drugs announced and old scores to settle.

Belgian pharma bosses 'accused of selling to Mexican drug baron'

Brussels - Belgian federal prosecutors are seeking to bring to court seven pharmaceutical executives accused of supplying a Mexican drug baron with the key ingredients for crystal meth, they said Wednesday.

India’s Ipca Laboratories receives FDA warning

Mumbai - The U.S. Food and Drug Administration has issued a warning notice to Ipca Laboratories, which is based in India, for data integrity issues.

Big Pharma wants governments to pay for new antibiotics

Human society needs a new generation of antimicrobials to overcome the problem of multi-drug resistance. A key question stemming from this is who should pick up the bill?

Johnson and Johnson hit by shares drop

U.S. healthcare colossus Johnson and Johnson saw a drop in its share value by 6 percent during 2015, according to the company’s latest financial statement.
  1 2 3 4 Next»

Set up a news alert for

Pharmaceuticals


Pharmaceuticals Image

Biogen is an American global biotechnology company based in Cambridge  Massachusetts  specializing i...
Biogen is an American global biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurodegenerative, hematologic, and autoimmune diseases to patients worldwide.
Biogen
U.S. drug company sues Canada for trying to lower cost of $700K-a-year drug
U.S. drug company sues Canada for trying to lower cost of $700K-a-year drug
Alexion Pharmaceuticals
Sativex contains marijuana-derived ingredients.
Sativex contains marijuana-derived ingredients.
Associated Press
Untitled
Grumpy-Puddin
Eli Lilly s global headquarters  Indianapolis  Indiana
Eli Lilly's global headquarters, Indianapolis, Indiana
Guanaco152003
A variety of statin drugs
A variety of statin drugs
Medicine vials on display at making Pharmaceuticals 2015.
Medicine vials on display at making Pharmaceuticals 2015.
Dr. Olumayokun Olajide s research will now look to produce compound derivatives of punicalagin for a...
Dr. Olumayokun Olajide's research will now look to produce compound derivatives of punicalagin for a drug that would treat neuro-inflammation, slowing down the progression of Alzheimer's
University of Huddersfield
Project Team at work:  Expertise helps AbbVie develop and enhance products and therapies to treat co...
Project Team at work: Expertise helps AbbVie develop and enhance products and therapies to treat conditions including HIV, arthritis, immunological and metabolic disorders, heart disease, and cancer.
© AbbVie Inc.

Latest News
Top News